ConductScience.org, home

Paper · 37569882

Molecular Mechanisms Underlying Chronic and Degenerative Diseases.

Cannavo A. Int J Mol Sci, 2023. Cited by 2 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Molecular Mechanisms Underlying Chronic and Degenerative Diseases. Papers, record 37569882. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37569882

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Molecular Mechanisms Underlying Chronic and Degenerative Diseases.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2023
PubMed
Publication types
Editorial, Introductory Journal Article
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.28
iCite
Revised in PubMed
2026-03-10
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cannavo AAlessandrohttps://orcid.org/0000-0001-8948-5961

Source PubMed

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Neurodegenerative DiseasesMajor topic
Humans
Chronic Disease
Animals

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128,785,469Global Public Health Burden of Heart Failure.Card Fail Rev2017https://conductscience.org/library/papers/28785469PubMed
235,805,938Seventy-Two-Hour LRRK2 Kinase Activity Inhibition Increases Lysosomal GBA Expression in H4, a Human Neuroglioma Cell Line.Int J Mol Sci2022https://conductscience.org/library/papers/35805938PubMed
336,902,342Simvastatin Improves Benign Prostatic Hyperplasia: Role of Peroxisome-Proliferator-Activated Receptor-γ and Classic WNT/β-Catenin Pathway.Int J Mol Sci2023https://conductscience.org/library/papers/36902342PubMed
435,409,005Transcriptional Regulation of the Synaptic Vesicle Protein Synaptogyrin-3 (SYNGR3) Gene: The Effects of NURR1 on Its Expression.Int J Mol Sci2022https://conductscience.org/library/papers/35409005PubMed
535,628,357Galectin 1-A Key Player between Tissue Repair and Fibrosis.Int J Mol Sci2022https://conductscience.org/library/papers/35628357PubMed
635,269,919Myocardial GRK2 Reduces Fatty Acid Metabolism and β-Adrenergic Receptor-Mediated Mitochondrial Responses.Int J Mol Sci2022https://conductscience.org/library/papers/35269919PubMed
736,555,487
Dorsolateral Prefrontal Cortex Glutamate/Gamma-Aminobutyric Acid (GABA) Alterations in Clinical High Risk and First-Episode Schizophrenia: A Preliminary 7-T Magnetic Resonance Spectroscopy Imaging Study.
Int J Mol Sci2022https://conductscience.org/library/papers/36555487PubMed
825,850,975The effects of statins on benign prostatic hyperplasia in elderly patients with metabolic syndrome.World J Urol2015https://conductscience.org/library/papers/25850975PubMed
925,229,124Association between metabolic syndrome and severity of lower urinary tract symptoms (LUTS): an observational study in a 4666 European men cohort.BJU Int2015https://conductscience.org/library/papers/25229124PubMed
1031,804,465LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson's disease patients.Nat Commun2019https://conductscience.org/library/papers/31804465PubMed

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
41,083,790Retinal degeneration driven by brain-derived neurotrophic factor deficiency in microglia and T-lymphocytes.Sci Rep2025https://conductscience.org/library/papers/41083790PubMed
37,762,040Neurodegenerative Diseases: Molecular Mechanisms and Therapies.Int J Mol Sci2023https://conductscience.org/library/papers/37762040PubMed

Genes10

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37569882

GET https://conductscience.org/api/papers/v1/37569882/authors